Abbvie Inc. vs STERIS plc
ABBV vs STE — side-by-side comparison from reported financials. ABBV leads 5, STE leads 7 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
| Metric | ABBV | STE |
|---|---|---|
| Price | $276.43 | $214.40 |
| Market cap | $488B | $20.9B |
| Revenue (TTM) | $64.4B | $6.04B |
| Revenue growth | +1.8% | +6.2% |
| Net margin | 9.8% | 13.3% |
| Free cash flow | $18.2B | $926M |
| Net cash (debt) | ($56.2B) | ($1.65B) |
| 1-year price return | +19.8% | -10.5% |
| P/E | 77.4 | 26.0 |
| P/E vs own history (cheap-side %) | 23% | 97% |
| Dividend yield | 2.45% | 1.18% |
| Return on equity | 96% | 11% |
| Altman Z-score | 2.33 | 4.34 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 17,937 |
Full résumé-style profiles: ABBV CV · STE CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.